TCTR20230401002已完成不适用
Treatment outcomes in cytomegalovirus anterior uveitis
/A0 个研究点目标入组 75 人开始时间: 2023年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.Patients with signs and symptoms which are compatible with cytomegalovirus anterior uveitis
- •2.Patients with aqueous PCR positive for cytomegalovirus
- •3.Patients who was treated with topical or systemic ganciclovir
排除标准
- •1.Patients who were diagnosed as CMV intermediate uveitis or CMV retinitits
- •2.Patients who were diagnosed as uveitis from other causes e.g. Infection, Autoimmune disease, Idiopathic
- •3.Patients with aqueous PCR positive for other organism or mixed organism
- •4.Patients who were treated with combination therapy
- •5.Immunocompromised patients
- •6.Patients with age under 18
- •7.In case of failure in first treatment protocol and other treatments were introduced. Data collection will select only first treatment protocol as failure of treatment
研究者
相似试验
招募中
3 期
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: a multicenter, open-label randomized controlled clinical trialHIV/AIDSCytomegalovirus pneumoniaRespiratoryPaediatricsTuberculosisPACTR201904797961340Servicio Madrileno de Salud Fundacion para la Investigacion Biomedica Hospital Universitario 12 de Octubre624
已完成
3 期
CONgenital Cytomegalovirus: Efficacy of antiviral treatment in a non-Randomized Trial with historical control groupcongenital cytomegalovirus (CMV)100407921001924310012562NL-OMON41461eids Universitair Medisch Centrum50
进行中（未招募）
1 期
Efficacy of antiviral treatment of congenital cytomegalovirus in a non-randomized trial with historical control groupCongenital cytomegalovirus infection.Sensorineural Hearingloss.MedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2013-003068-30-NLMC50
招募中
不适用
Impact of Superimposed Cytomegalovirus Infection on the Outcomes of Ulcerative Colitis Flare-upDiseases of the digestive systemKCT0003296Kyung Hee University Hospital150
进行中（未招募）
不适用
Efficacy and safety of anti-cytomegalovirus prophylaxis versus pre-emptive approaches with valganciclovir in heart transplant recipients treated with everolimus or mycophenolate. A randomized open-label study for prevention of cardiac allograft vasculopathy - PROTECTHeart transplantationMedDRA version: 9.1Level: LLTClassification code 10019315Term: Heart transplant rejectionEUCTR2008-006980-35-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI